D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 19,813 430 World Ranking 12981 National Ranking 458

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Osteoporosis, Surgery and Rheumatology. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Physical therapy. The concepts of his Rheumatoid arthritis study are interwoven with issues in Connective tissue disease, Methotrexate, Infliximab and Arthritis.

Willem F. Lems has researched Osteoporosis in several fields, including N-terminal telopeptide, Placebo, Ankylosing spondylitis and Bone remodeling. His Surgery study incorporates themes from Combination therapy and Cohort. His Rheumatology research includes elements of Erythrocyte sedimentation rate and Oncology.

His most cited work include:

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial (1291 citations)
  • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. (574 citations)
  • Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis (472 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Rheumatoid arthritis, Physical therapy, Osteoarthritis and Osteoporosis are his primary areas of study. In Internal medicine, he works on issues like Surgery, which are connected to Functional ability. His work deals with themes such as Methotrexate, Infliximab, Disease and Combination therapy, which intersect with Rheumatoid arthritis.

His work carried out in the field of Physical therapy brings together such families of science as Body mass index, Randomized controlled trial, Exercise therapy and Comorbidity. Muscle strength is closely connected to Cohort in his research, which is encompassed under the umbrella topic of Osteoarthritis. His Osteoporosis research is multidisciplinary, incorporating elements of Incidence and Bone remodeling.

He most often published in these fields:

  • Internal medicine (55.24%)
  • Rheumatoid arthritis (37.67%)
  • Physical therapy (30.24%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (55.24%)
  • Osteoarthritis (23.65%)
  • Rheumatoid arthritis (37.67%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Osteoarthritis, Rheumatoid arthritis, Physical therapy and Osteoporosis. His study in Osteoarthritis is interdisciplinary in nature, drawing from both Knee Joint, Physical medicine and rehabilitation and Cohort. Rheumatoid arthritis is a subfield of Immunology that Willem F. Lems tackles.

In his work, WOMAC is strongly intertwined with Body mass index, which is a subfield of Physical therapy. His Osteoporosis research incorporates elements of Ankylosing spondylitis, Bone remodeling and Intensive care medicine. His Rheumatology research includes themes of Bone mineral and Orthopedic surgery.

Between 2016 and 2021, his most popular works were:

  • Biologic therapies and bone loss in rheumatoid arthritis. (64 citations)
  • Inflammatory diseases and bone fragility (62 citations)
  • Efficacy of tailored exercise therapy on physical functioning in patients with knee osteoarthritis and comorbidity : A randomized controlled trial (48 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His main research concerns Internal medicine, Rheumatoid arthritis, Osteoporosis, Disease and Osteoarthritis. His studies link Endocrinology with Internal medicine. His work on Antirheumatic Agents is typically connected to Cobra as part of general Rheumatoid arthritis study, connecting several disciplines of science.

His Osteoporosis research incorporates themes from Zoledronic acid, Ankylosing spondylitis, Bone remodeling and Urology. His Osteoarthritis research is multidisciplinary, incorporating perspectives in Degeneration, Physical therapy and Clinical psychology. Willem F. Lems has included themes like Discontinuation, Randomized controlled trial, Surgery, Pharmacotherapy and Vitamin D and neurology in his Arthritis study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben.
Arthritis & Rheumatism (2005)

1976 Citations

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg.
JAMA (2011)

839 Citations

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel.
Annals of the Rheumatic Diseases (2007)

681 Citations

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl.
Arthritis & Rheumatism (2006)

611 Citations

Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation

V P van Halm;M J L Peters;A E Voskuyl;M Boers.
Annals of the Rheumatic Diseases (2009)

502 Citations

Does Rheumatoid Arthritis Equal Diabetes Mellitus as an Independent Risk Factor for Cardiovascular Disease? A Prospective Study

Mike J. L. Peters;Vokko P. van Halm;Alexandre E. Voskuyl;Yvo M. Smulders.
Arthritis & Rheumatism (2009)

452 Citations

Republished: Value of biomarkers in osteoarthritis: current status and perspectives

M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi.
Postgraduate Medical Journal (2014)

375 Citations

Value of biomarkers in osteoarthritis: current status and perspectives

M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi.
Annals of the Rheumatic Diseases (2013)

324 Citations

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

M Vis;E A Havaardsholm;G Haugeberg;T Uhlig.
Annals of the Rheumatic Diseases (2006)

297 Citations

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven O Stapel.
Annals of the Rheumatic Diseases (2010)

293 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Willem F. Lems

Paul Emery

Paul Emery

University of Leeds

Publications: 111

Cyrus Cooper

Cyrus Cooper

University of Southampton

Publications: 97

Piet Geusens

Piet Geusens

Maastricht University

Publications: 70

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 69

Tom W. J. Huizinga

Tom W. J. Huizinga

Leiden University Medical Center

Publications: 61

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 57

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 57

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 56

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 56

Maarten Boers

Maarten Boers

Vrije Universiteit Amsterdam

Publications: 56

Georg Schett

Georg Schett

University of Erlangen-Nuremberg

Publications: 53

Theo Rispens

Theo Rispens

University of Amsterdam

Publications: 53

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 52

John A. Kanis

John A. Kanis

Australian Catholic University

Publications: 52

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 51

Jeffrey R. Curtis

Jeffrey R. Curtis

University of Alabama at Birmingham

Publications: 48

Trending Scientists

Franco Zappa

Franco Zappa

Polytechnic University of Milan

Simon N. Chandler-Wilde

Simon N. Chandler-Wilde

University of Reading

Ranjan Mukherjee

Ranjan Mukherjee

Michigan State University

Tomy Varghese

Tomy Varghese

University of Wisconsin–Madison

Jonas Sjöberg

Jonas Sjöberg

Chalmers University of Technology

Pratim K. Chattaraj

Pratim K. Chattaraj

Indian Institute of Technology Kharagpur

Hiromichi Ohta

Hiromichi Ohta

Hokkaido University

John F. Bateman

John F. Bateman

University of Melbourne

Peter S. Chines

Peter S. Chines

National Institutes of Health

Philip A. Stansly

Philip A. Stansly

University of Florida

Katsuaki Hoshino

Katsuaki Hoshino

Kagawa University

Luis Gimeno

Luis Gimeno

Universidade de Vigo

John W. Rohrbaugh

John W. Rohrbaugh

Washington University in St. Louis

Stephen J. Pandol

Stephen J. Pandol

Cedars-Sinai Medical Center

Joel S. Weissman

Joel S. Weissman

Brigham and Women's Hospital

Something went wrong. Please try again later.